サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420965

インフルエンザ診断市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年

Influenza Diagnostics Market (Test Type: RT-PCR Tests, Rapid Influenza Diagnostic Tests, Viral Culture, Immunofluorescence Assays, Serological Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 172 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
インフルエンザ診断市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年
出版日: 2023年12月29日
発行: Transparency Market Research
ページ情報: 英文 172 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インフルエンザ診断市場 - レポートの範囲

世界のインフルエンザ診断市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界のインフルエンザ診断市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。このレポートは、2023年から2031年までの世界のインフルエンザ診断市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、インフルエンザ診断市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 13億米ドル
2031年の市場価値 20億米ドル
CAGR 5.6%

このレポートは、世界のインフルエンザ診断市場の競合情勢を詳しく調査しています。世界のインフルエンザ診断市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のインフルエンザ診断市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 重要な洞察

  • 病気の疫学
  • 償還シナリオ
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場分析と予測：インフルエンザウイルスタイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：インフルエンザウイルスタイプ別、2017年～2031年
    • タイプA
    • タイプB
  • 市場魅力度分析：インフルエンザウイルスタイプ別

第7章 世界市場の分析と予測：検査タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：検査タイプ別、2017年～2031年
    • RT-PCR検査
    • インフルエンザ迅速診断検査（RIDT）
    • ウイルス文化
    • 免疫蛍光アッセイ
    • 血清学的検査
    • その他（LAMP、SAMBAなど）
  • 市場魅力度分析：検査タイプ別

第8章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：製品タイプ別、2017年～2031年
    • キットと試薬
    • 機器
    • その他
  • 市場魅力度分析：製品タイプ別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 病院
    • 診断センター
    • その他（学術研究機関等）
  • 市場魅力度分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東・アフリカ市場の分析と予測

第16章 競合情勢

  • 市場企業 - 競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • 3M
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Company
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Goldsite Diagnostics Inc.
    • Hologic, Inc.
    • DiaSorin SpA
    • Meridian Bioscience, Inc.
    • QuidelOrtho Corporation
    • SA Scientific Ltd.
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Thermo Fisher Scientific
図表

List of Tables

  • Table 01: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 02: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 03: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 04: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 08: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 09: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 10: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 13: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 14: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 18: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 19: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 20: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 23: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 24: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 25: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 28: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 29: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 30: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Influenza Diagnostics Market Size, by Flu Virus Type, 2022
  • Figure 02: Global Influenza Diagnostics Market Share (%), by Flu Virus Type, 2022
  • Figure 03: Global Influenza Diagnostics Market Size, by Test Type, 2022
  • Figure 04: Global Influenza Diagnostics Market Share (%), by Test Type, 2022
  • Figure 05: Global Influenza Diagnostics Market Size, by Product Type, 2022
  • Figure 06: Global Influenza Diagnostics Market Share (%), by Product Type, 2022
  • Figure 07: Global Influenza Diagnostics Market Size, by End-user, 2022
  • Figure 08: Global Influenza Diagnostics Market Share (%), by End-user, 2022
  • Figure 09: Global Influenza Diagnostics Market, by Region (2022 and 2031)
  • Figure 10: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 12: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022
  • Figure 13: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2031
  • Figure 14: Global Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 15: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 16: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022
  • Figure 17: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2031
  • Figure 18: Global Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 19: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 20: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022
  • Figure 21: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2031
  • Figure 22: Global Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 23: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 25: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 26: Global Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 29: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 30: Global Influenza Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 31: North America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: North America Influenza Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 33: North America Influenza Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 34: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 35: North America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 36: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 37: North America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-31
  • Figure 38: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 39: North America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-31
  • Figure 40: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 41: North America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 42: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 43: Europe Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 44: Europe Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 45: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 46: Europe Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 47: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 48: Europe Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 49: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 50: Europe Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 51: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Europe Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 53: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 57: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 58: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 59: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 60: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 61: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 62: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 63: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 64: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 65: Latin America Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 66: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 68: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 69: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 70: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 71: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 72: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 73: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 74: Latin America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 75: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 76: Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 77: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 78: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 79: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 80: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 81: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 82: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 83: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 84: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 85: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL17435

Influenza Diagnostics Market - Scope of Report

TMR's report on the global influenza diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global influenza diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global influenza diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the influenza diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.3 Bn
Market Value in 2031US$ 2 Bn
CAGR5.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global influenza diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global influenza diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global influenza diagnostics market.

The report delves into the competitive landscape of the global influenza diagnostics market. Key players operating in the global influenza diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global influenza diagnostics market profiled in this report.

Key Questions Answered in Global influenza diagnostics Market Report:

  • What is the sales/revenue generated by influenza diagnostics across all regions during the forecast period?
  • What are the opportunities in the global influenza diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Influenza Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global influenza diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global influenza diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global influenza diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Influenza Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Influenza Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Reimbursement Scenario
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Influenza Diagnostics Market Analysis and Forecast, by Flu Virus Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 6.3.1. Type A
    • 6.3.2. Type B
  • 6.4. Market Attractiveness Analysis, by Flu Virus Type

7. Global Influenza Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Test Type, 2017-2031
    • 7.3.1. RT-PCR Tests
    • 7.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 7.3.3. Viral Culture
    • 7.3.4. Immunofluorescence Assays
    • 7.3.5. Serological Tests
    • 7.3.6. Others (LAMP, SAMBA, etc.)
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global Influenza Diagnostics Market Analysis and Forecast, by Product Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Product Type, 2017-2031
    • 8.3.1. Kits & Reagents
    • 8.3.2. Instrument
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Product Type

9. Global Influenza Diagnostics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others (academics & research institutes, etc.)
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Influenza Diagnostics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Influenza Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 11.2.1. Type A
    • 11.2.2. Type B
  • 11.3. Market Value Forecast, by Test Type, 2017-2031
    • 11.3.1. RT-PCR Tests
    • 11.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 11.3.3. Viral Culture
    • 11.3.4. Immunofluorescence Assays
    • 11.3.5. Serological Tests
    • 11.3.6. Others (LAMP, SAMBA, etc.)
  • 11.4. Market Value Forecast, by Product Type, 2017-2031
    • 11.4.1. Kits & Reagents
    • 11.4.2. Instrument
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Others (academics & research institutes, etc.)
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Flu Virus Type
    • 11.7.2. By Test Type
    • 11.7.3. By Product Type
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Influenza Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 12.2.1. Type A
    • 12.2.2. Type B
  • 12.3. Market Value Forecast, by Test Type, 2017-2031
    • 12.3.1. RT-PCR Tests
    • 12.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 12.3.3. Viral Culture
    • 12.3.4. Immunofluorescence Assays
    • 12.3.5. Serological Tests
    • 12.3.6. Others (LAMP, SAMBA, etc.)
  • 12.4. Market Value Forecast, by Product Type, 2017-2031
    • 12.4.1. Kits & Reagents
    • 12.4.2. Instrument
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Others (academics & research institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Flu Virus Type
    • 12.7.2. By Test Type
    • 12.7.3. By Product Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Influenza Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 13.2.1. Type A
    • 13.2.2. Type B
  • 13.3. Market Value Forecast, by Test Type, 2017-2031
    • 13.3.1. RT-PCR Tests
    • 13.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 13.3.3. Viral Culture
    • 13.3.4. Immunofluorescence Assays
    • 13.3.5. Serological Tests
    • 13.3.6. Others (LAMP, SAMBA, etc.)
  • 13.4. Market Value Forecast, by Product Type, 2017-2031
    • 13.4.1. Kits & Reagents
    • 13.4.2. Instrument
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Others (academics & research institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Flu Virus Type
    • 13.7.2. By Test Type
    • 13.7.3. By Product Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Influenza Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 14.2.1. Type A
    • 14.2.2. Type B
  • 14.3. Market Value Forecast, by Test Type, 2017-2031
    • 14.3.1. RT-PCR Tests
    • 14.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 14.3.3. Viral Culture
    • 14.3.4. Immunofluorescence Assays
    • 14.3.5. Serological Tests
    • 14.3.6. Others (LAMP, SAMBA, etc.)
  • 14.4. Market Value Forecast, by Product Type, 2017-2031
    • 14.4.1. Kits & Reagents
    • 14.4.2. Instrument
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Others (academics & research institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Flu Virus Type
    • 14.7.2. By Test Type
    • 14.7.3. By Product Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Influenza Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 15.2.1. Type A
    • 15.2.2. Type B
  • 15.3. Market Value Forecast, by Test Type, 2017-2031
    • 15.3.1. RT-PCR Tests
    • 15.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 15.3.3. Viral Culture
    • 15.3.4. Immunofluorescence Assays
    • 15.3.5. Serological Tests
    • 15.3.6. Others (LAMP, SAMBA, etc.)
  • 15.4. Market Value Forecast, by Product Type, 2017-2031
    • 15.4.1. Kits & Reagents
    • 15.4.2. Instrument
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Centers
    • 15.5.3. Others (academics & research institutes, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Flu Virus Type
    • 15.7.2. By Test Type
    • 15.7.3. By Product Type
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. 3M
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Abbott
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. F. Hoffmann-La Roche Ltd.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Becton, Dickinson and Company
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. BIOMERIEUX
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bio-Rad Laboratories, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Goldsite Diagnostics Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Hologic, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. DiaSorin S.p.A.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Meridian Bioscience, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. QuidelOrtho Corporation
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. SA Scientific Ltd.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Sekisui Diagnostics
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Siemens Healthineers
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
    • 16.3.15. Thermo Fisher Scientific
      • 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.15.2. Product Portfolio
      • 16.3.15.3. Financial Overview
      • 16.3.15.4. SWOT Analysis
      • 16.3.15.5. Strategic Overview